基底细胞癌病理要求和报告缺乏重要信息。

IF 1.2 Q3 DERMATOLOGY
Journal of Skin Cancer Pub Date : 2019-01-03 eCollection Date: 2019-01-01 DOI:10.1155/2019/4876309
Firas Al-Qarqaz, Khaldon Bodoor, Awad Al-Tarawneh, Haytham Eloqayli, Wisam Al Gargaz, Diala Alshiyab, Jihan Muhaidat, Mohammad Alqudah, Rowida Almomani, Maha Marji
{"title":"基底细胞癌病理要求和报告缺乏重要信息。","authors":"Firas Al-Qarqaz,&nbsp;Khaldon Bodoor,&nbsp;Awad Al-Tarawneh,&nbsp;Haytham Eloqayli,&nbsp;Wisam Al Gargaz,&nbsp;Diala Alshiyab,&nbsp;Jihan Muhaidat,&nbsp;Mohammad Alqudah,&nbsp;Rowida Almomani,&nbsp;Maha Marji","doi":"10.1155/2019/4876309","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Basal cell carcinoma (BCC) is the most common cancer affecting humans. Luckily it has negligible risk for metastasis; however it can be locally destructive to surrounding tissue. The diagnosis of this tumor relies on clinical and dermoscopic features; however confirmation requires biopsy and histologic examination. Based on clinical and pathologic findings, BCC is classified as low or high risk subtype. The clinician requesting pathology examination for BCC should provide the pathologist with detailed information including patient details, relevant clinical and medical history, site and type of the biopsy, and whether this is a primary or recurrent lesion. The pathologist on the other hand should write an adequate report containing a minimum of core set of parameters including type of BCC, depth of invasion, presence of lymphovascular or perineural invasion, and the excision margins.</p><p><strong>Objectives: </strong>The objective of this study is to evaluate whether requests by clinicians and pathology reports of BCC are adequate.</p><p><strong>Methods: </strong>This is a retrospective analysis done at the dermatology department, faculty of medicine at Jordan University of Science and Technology, Irbid, Jordan. Reports for the period from January 2003 to December 2017 were retrieved and analyzed for data completeness.</p><p><strong>Results: </strong>Most clinical request forms of BCC provided by clinicians are inadequate and lack important relevant information especially in regard to lesion history, patient medical history, and whether BCC is a primary or a recurrent one. Pathology reports for BCC cases also have significant deficiency especially in describing the histologic subtype, depth of invasion, and presence of lymphovascular and perineural invasion. However, the tumor excision margins are adequately described in almost all reports.</p><p><strong>Conclusions: </strong>The study shows that clinicians do not provide adequate clinical information when submitting a request for histopathologic examination of BCC. Similarly, pathologists write incomplete reports that lack important pathologic features. Having pre-set forms (electronic proforma) can help overcome missing information.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2019 ","pages":"4876309"},"PeriodicalIF":1.2000,"publicationDate":"2019-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/4876309","citationCount":"5","resultStr":"{\"title\":\"Basal Cell Carcinoma Pathology Requests and Reports Are Lacking Important Information.\",\"authors\":\"Firas Al-Qarqaz,&nbsp;Khaldon Bodoor,&nbsp;Awad Al-Tarawneh,&nbsp;Haytham Eloqayli,&nbsp;Wisam Al Gargaz,&nbsp;Diala Alshiyab,&nbsp;Jihan Muhaidat,&nbsp;Mohammad Alqudah,&nbsp;Rowida Almomani,&nbsp;Maha Marji\",\"doi\":\"10.1155/2019/4876309\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Basal cell carcinoma (BCC) is the most common cancer affecting humans. Luckily it has negligible risk for metastasis; however it can be locally destructive to surrounding tissue. The diagnosis of this tumor relies on clinical and dermoscopic features; however confirmation requires biopsy and histologic examination. Based on clinical and pathologic findings, BCC is classified as low or high risk subtype. The clinician requesting pathology examination for BCC should provide the pathologist with detailed information including patient details, relevant clinical and medical history, site and type of the biopsy, and whether this is a primary or recurrent lesion. The pathologist on the other hand should write an adequate report containing a minimum of core set of parameters including type of BCC, depth of invasion, presence of lymphovascular or perineural invasion, and the excision margins.</p><p><strong>Objectives: </strong>The objective of this study is to evaluate whether requests by clinicians and pathology reports of BCC are adequate.</p><p><strong>Methods: </strong>This is a retrospective analysis done at the dermatology department, faculty of medicine at Jordan University of Science and Technology, Irbid, Jordan. Reports for the period from January 2003 to December 2017 were retrieved and analyzed for data completeness.</p><p><strong>Results: </strong>Most clinical request forms of BCC provided by clinicians are inadequate and lack important relevant information especially in regard to lesion history, patient medical history, and whether BCC is a primary or a recurrent one. Pathology reports for BCC cases also have significant deficiency especially in describing the histologic subtype, depth of invasion, and presence of lymphovascular and perineural invasion. However, the tumor excision margins are adequately described in almost all reports.</p><p><strong>Conclusions: </strong>The study shows that clinicians do not provide adequate clinical information when submitting a request for histopathologic examination of BCC. Similarly, pathologists write incomplete reports that lack important pathologic features. Having pre-set forms (electronic proforma) can help overcome missing information.</p>\",\"PeriodicalId\":17172,\"journal\":{\"name\":\"Journal of Skin Cancer\",\"volume\":\"2019 \",\"pages\":\"4876309\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2019-01-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2019/4876309\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Skin Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2019/4876309\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Skin Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2019/4876309","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 5

摘要

基底细胞癌(BCC)是人类最常见的癌症。幸运的是,它的转移风险可以忽略不计;然而,它可能对周围组织造成局部破坏。该肿瘤的诊断依赖于临床和皮肤镜特征;然而,确认需要活检和组织学检查。根据临床和病理表现,BCC分为低危亚型和高危亚型。要求进行BCC病理检查的临床医生应向病理学家提供详细信息,包括患者的详细信息、相关的临床和病史、活检的部位和类型,以及这是原发性病变还是复发性病变。另一方面,病理学家应该写一份充分的报告,其中包含至少一组核心参数,包括BCC的类型、浸润深度、淋巴血管或神经周围浸润的存在以及切除边缘。目的:本研究的目的是评估临床医生的要求和BCC的病理报告是否足够。方法:回顾性分析在约旦伊尔比德约旦科技大学医学院皮肤科进行的研究。检索2003年1月至2017年12月期间的报告,并对其进行数据完整性分析。结果:临床医生提供的BCC临床申请表大多不充分,缺乏重要的相关信息,特别是在病变史、患者病史、BCC是原发性还是复发性方面。BCC病例的病理报告也有明显的不足,特别是在描述组织学亚型、浸润深度、淋巴血管和神经周围浸润的存在方面。然而,几乎所有的报告都充分描述了肿瘤切除的边缘。结论:该研究表明,临床医生在提交BCC组织病理学检查请求时没有提供足够的临床信息。同样,病理学家写的报告不完整,缺乏重要的病理特征。有预先设定的表格(电子形式)可以帮助克服丢失的信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Basal Cell Carcinoma Pathology Requests and Reports Are Lacking Important Information.

Basal Cell Carcinoma Pathology Requests and Reports Are Lacking Important Information.

Introduction: Basal cell carcinoma (BCC) is the most common cancer affecting humans. Luckily it has negligible risk for metastasis; however it can be locally destructive to surrounding tissue. The diagnosis of this tumor relies on clinical and dermoscopic features; however confirmation requires biopsy and histologic examination. Based on clinical and pathologic findings, BCC is classified as low or high risk subtype. The clinician requesting pathology examination for BCC should provide the pathologist with detailed information including patient details, relevant clinical and medical history, site and type of the biopsy, and whether this is a primary or recurrent lesion. The pathologist on the other hand should write an adequate report containing a minimum of core set of parameters including type of BCC, depth of invasion, presence of lymphovascular or perineural invasion, and the excision margins.

Objectives: The objective of this study is to evaluate whether requests by clinicians and pathology reports of BCC are adequate.

Methods: This is a retrospective analysis done at the dermatology department, faculty of medicine at Jordan University of Science and Technology, Irbid, Jordan. Reports for the period from January 2003 to December 2017 were retrieved and analyzed for data completeness.

Results: Most clinical request forms of BCC provided by clinicians are inadequate and lack important relevant information especially in regard to lesion history, patient medical history, and whether BCC is a primary or a recurrent one. Pathology reports for BCC cases also have significant deficiency especially in describing the histologic subtype, depth of invasion, and presence of lymphovascular and perineural invasion. However, the tumor excision margins are adequately described in almost all reports.

Conclusions: The study shows that clinicians do not provide adequate clinical information when submitting a request for histopathologic examination of BCC. Similarly, pathologists write incomplete reports that lack important pathologic features. Having pre-set forms (electronic proforma) can help overcome missing information.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Skin Cancer
Journal of Skin Cancer DERMATOLOGY-
CiteScore
2.30
自引率
18.20%
发文量
12
审稿时长
21 weeks
期刊介绍: Journal of Skin Cancer is a peer-reviewed, Open Access journal that publishes clinical and translational research on the detection, diagnosis, prevention, and treatment of skin malignancies. The journal encourages the submission of original research articles, review articles, and clinical studies related to pathology, prognostic indicators and biomarkers, novel therapies, as well as drug sensitivity and resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信